A detailed history of Pathstone Holdings, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Pathstone Holdings, LLC holds 22,006 shares of RPRX stock, worth $568,855. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,006
Previous 19,539 12.63%
Holding current value
$568,855
Previous $515,000 20.78%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$25.63 - $29.27 $63,229 - $72,209
2,467 Added 12.63%
22,006 $622,000
Q2 2024

Aug 14, 2024

BUY
$26.26 - $29.9 $1,995 - $2,272
76 Added 0.39%
19,539 $515,000
Q1 2024

May 13, 2024

BUY
$27.46 - $31.33 $191,423 - $218,401
6,971 Added 55.8%
19,463 $591,000
Q4 2023

Feb 14, 2024

BUY
$26.21 - $29.22 $327,415 - $365,016
12,492 New
12,492 $350,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.3B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.